Midlife Women: A Critical Window for Alzheimer’s Prevention A growing body of research suggests that the midlife transition, particularly menopause, represents a crucial period for Alzheimer’s disease (AD) prevention in …
Tag:
Metabolism
-
-
Unlocking Tuberculosis’s Energy Source: A New Path to Treatment Researchers have made a significant breakthrough in understanding how Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB), fuels itself during infection. …
-
GLP-1 Weight Loss Drugs: Many Patients Restart or Switch Therapies After Stopping A recent study indicates that many individuals who discontinue glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications for weight …
-
New Genetic Risk Score Better Predicts Diabetes, Obesity, and Related Health Risks A newly developed genetic risk score (PRS) is demonstrating improved accuracy in predicting the development of type 2 …
-
Sleep Duration and Type 2 Diabetes Risk: Finding the Optimal Balance The amount of sleep a person gets each night can significantly influence their risk of developing type 2 diabetes. …
-
Gut Microbiome May Predict Response to GLP-1 Weight Loss Medications New research highlights the growing understanding of how the gut microbiome influences the effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1 …
-
Low Testosterone and High Fructose: A Dangerous Combination for Liver Health Men with low testosterone levels may face a significantly increased risk of developing fatty liver disease, particularly when combined …
-
The Gut-Brain Connection: How Diet and Lifestyle Impact Irritable Bowel Syndrome and Overall Health For individuals grappling with the unpredictable symptoms of Irritable Bowel Syndrome (IBS)—abdominal pain, bloating, and altered …
-
Vitamin B2 Shows Promise in New Cancer Therapies A deficiency in vitamin B2, also known as riboflavin, may increase the susceptibility of tumor cells to a specific type of cell …
-
CD4+ T Cells: Reframing Cancer Immunotherapy For decades, cancer immunotherapy has largely focused on CD8+ cytotoxic T lymphocytes as the primary drivers of tumor cell destruction. However, emerging clinical evidence …